In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
Sadaf Emad-Vaez, PharmD Candidate
Advertisement
Articles by Sadaf Emad-Vaez, PharmD Candidate
Advertisement
Latest Updated Articles
Use of Multiple Sclerosis Disease-Modifying Therapies During COVID-19 PandemicPublished: September 15th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Incidence of Invasive Fungal Infections Following BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
5
